This product is a chimeric (mouse/human) monoclonal antibody with glycosylation site in Fc region. The Ch14.18 with enhanced ADCC specifically binds human GD2 and can be potentially used in the treatment of high-risk neuroblastoma.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-099 | Mouse Anti-GCGR Recombinant Antibody (clone mAb7) | ELISA, WB, FuncS | Mouse IgG |
PABL-480 | Recombinant Human Anti-GCGR Antibody (mAb1) | WB, ELISA, FuncS | IgG |
HPAB-0105LY | Human Anti-GCGR Recombinant Antibody (HPAB-0105LY) | ELISA | Human IgG |
HPAB-3385LY | Human Anti-GCGR Recombinant Antibody (clone CBL150) | ELISA | Human IgG |
HPAB-3386LY | Human Anti-GCGR Recombinant Antibody (clone CBL151) | ELISA | Human IgG |
There are currently no Customer reviews or questions for Gly-113LC. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.